ANGIOGENESIS / VASCULAR DIFFERENTIATION |
|
— Anti-angiogenic therapy |
L16, L242, L29, O216, P135, P138, P139, P282 |
— Collaterals / Arteriogenesis |
O2, O68, P136, P157, P184, P190, P280, P302, P307 |
— Lymphangiogenesis |
K201, P309 |
— Therapeutic angiogenesis / therapeutic arteriogenesis |
O21, O46, O69, P103, P121, P252, P306, P341, P87, P88, P91 |
— Tumor vascularisation |
L238, O48, P125, P126, P127, P128, P275 |
— Vasculogenesis |
L20, L235, L55, L58, L59, O18, O211, O24, O4, O45, O50, P129, P130, P131, P132, P133, P134, P173, P178, P262, P305, P310, P312, P343, P80, P82 |
ARTIFICIAL BLOOD VESSELS AND TISSUE ENGINEERING |
|
— Endothelial seeding |
P78 |
— Vascular and myocardial tissue engineering |
L19, L20, O21 |
ATHEROSCLEROSIS AND RESTENOSIS |
|
— Animal models |
L47, O236, P290, P320 |
— Brachytherapy for restenosis |
P350 |
— Cell biology of atherosclerostic lesions |
L15, L234, O213, O243, O39, O5, O72, P151, P154, P155, P156, P158, P245, P288, P289, P321, P322, P325 |
— Cell biology of restenosis |
L56, P268 |
— Gene therapy of restenosis |
O63, P336 |
— Imaging of cell-cell interactions in vivo |
L23 |
— Initiation and progression of lesions |
L52, O231, O233, O25, O33, O36, O64, P101, P119, P153, P159, P160, P197, P250, P263, P292, P318, P323, P324, P344, P345, P346 |
— Molecular plaque imaging - experimental |
L221, L222, L23, O223 |
— Molecular plaque imaging - clinical |
L221, O230 |
— Pharmacological approaches to restenosis |
P137, P334 |
— Restenosis - experimental |
O244, O77, P177, P198, P330, P78 |
— Restenosis - clinical |
P192, P193 |
CELL DEATH AND VASCULAR REMODELLING |
|
— Apoptosis |
O220, O72, P116, P139, P155, P337, P354 |
— Necrosis |
L32 |
— Vascular remodelling |
O33, P332, P337, P89 |
CELL GROWTH |
|
— Cell cycle control |
K42 |
— Growth factors / inhibitors |
L28, L356, O18, O50, P184, P335 |
— Response to injury |
P267 |
DIABETES, METABOLIC DISORDERS, AND AGEING |
|
— Adipokines |
L235, P187, P343, P347 |
— Ageing |
P124, P340 |
— Insulin, insulin resistance |
L234, O210, P175, P180 |
— Lipids and oxidative stress |
O69, P104, P304, P348, P95 |
— Lipoproteins and cholesterol |
P148, P183, P185, P304, P348 |
DIFFERENTIATION AND FUNCTION OF VASCULAR CELLS |
|
— Monocytes |
L44, P152, P157 |
— Smooth muscle cells |
L74, P117, P120, P159, P198, P339, P340 |
— Vascular stem cells - basic research |
L1, L74, O212, O24, O3, O38, P305, P341, P79, P80, P81, P85, P86, P90, P92, P95 |
— Vascular stem cells - clinical research |
P87 |
ENDOTHELIAL FUNCTION AND DYSFUNCTION |
|
— Cellular mechanisms |
L241, L28, L32, L59, L8, O205, O206, O210, O219, O38, O40, P115, P142, P189, P267, P272, P274, P282, P285, P317, P353, P96, P98 |
— In vivo - clinical |
L225, O209, O237, P101, P111, P118, P186, P291, P292, P298, P299, P342, P93, P97 |
— Mechanisms, markers and mediators |
L218, O17, O207, O208, O232, O34, P106, P107, P108, P109, P110, P124, P140, P176, P197, P273, P286, P293, P294, P301, P311, P333, P97 |
FLOW REGULATION AND OXYGEN DELIVERY |
|
— Hypoxia |
O13 |
— Metabolic control of flow |
P270 |
— Microcirculatory hemodynamics |
O27, P128, P94 |
— Systemic hemodynamics |
O26, P100, P163, P79 |
HYPERTENSION / BLOOD PRESSURE CONTROL |
|
— Autonomic nervous system |
P248 |
— Genetics |
P246 |
— Hormones and mediators |
P253, P262, P338 |
— Pharmacotherapy |
O237, P105, P171, P175 |
INFLAMMATION AND LEUKOCYTE BIOLOGY |
|
— Cytokines |
L15, L227, O208, P151, P339, P353 |
— Endothelial-leukocyte interaction |
L16, L56, P308, P322, P342, P349 |
— Immunopathy and inflammation |
L227, P195, P351 |
— Inflammatory cells |
L61, O62, P154, P287, P288, P289, P321, P325, P352 |
— Inflammatory mediators |
L52, L54, P162, P179, P182, P187, P192, P194, P196, P315, P347 |
— Vascular response to infection |
P114, P297 |
ISCHEMIA-REPERFUSION |
|
— Ischemic injury |
P112, P264, P265, P296, P84 |
— Organ protection |
L7, P355 |
— Reperfusion injury |
L8, L9, P141 |
— Revascularisation |
P257, P261, P310 |
MATRIX PROTEINS / METALLOPROTEINASES |
|
— Components of extracellular matrix |
O213, O229 |
— Metalloproteinases |
K42, L61, O215, O216, O62, O63, O64, P313, P314, P315, P317 |
— Remodelling of extracellular matrix |
O211, O214, P168, P251, P324 |
MICROCIRCULATORY NETWORKS |
|
— Microvascular growth patterns |
P127 |
— Structure and regulation of microvascular beds |
L66, L67, O27, P164, P181, P247, P266, P308 |
THROMBOLYSIS, HEMOSTASIS, AND PLATELETS |
|
— Coagulation |
O73, P143, P144, P147, P196, P326 |
— Platelet-derived products |
L70 |
— Platelet function |
L226, L71, O244, P145, P146, P150 |
— Platelet inhibition |
P142, P149 |
VASCULAR GENE THERAPY |
|
— Clinical applications |
P84 |
— siRNA |
P316 |
— Techniques of transfection |
L9, P249, P251 |
— Viral vectors |
O46, P319 |
VASCULAR GENETICS, GENOMICS AND PROTEOMICS |
|
— Genetic mechanisms of vascular disease |
L10, P153, P254, P314 |
— Vascular genomics |
O231, O51, P115, P162, P245, P255, P300 |
— Vascular proteomics |
O49, P280, P85 |
VASCULAR PERMEABILITY AND FLUID EXCHANGE |
|
— Endothelial permeability in vitro |
P258, P269, P281, P283, P284, P295 |
— Vascular permeability of intact vessels |
P269 |
VASCULAR RESPONSES TO MECHANICAL LOAD |
|
— Cytoskeletal restructuring |
O22 |
— Mechanotransduction |
O76, P167, P168, P169, P170 |
— pressure / stretch / cyclic strain |
O214, O22, O65, P164, P165, P170, P171, P174, P188, P191, P329 |
— Shear stress |
O26, P163, P166, P169, P172, P173 |
VASCULAR SIGNAL TRANSDUCTION |
|
— Calcium and second messengers |
L225, P258, P295 |
— G-protein coupled receptors |
O204, P100, P276, P327, P328 |
— Ion channels |
P279, P331 |
— Lipid signalling |
L53 |
— Protein kinases / phosphatases |
L67, O203, O219, P275, P277, P284, P326, P327 |
— Receptor tyrosine kinases |
L29, L44, P126, P256, P329 |
— Redox signalling |
O11, O12, O14, O205, P113, P116, P332 |
— Transcription factors |
O13, O3, O35, O76, P120, P130, P161, P166 |
VASOACTIVE FACTORS |
|
— Adenosine |
P276 |
— Angiotensin and ACE |
O37 |
— EDHF |
P271 |
— Eicosanoids |
O77 |
— Endothelin |
P158, P253 |
— Nitric oxide |
L218, P102, P104, P109, P123, P260, P278, P293, P294, P303, P91, P96, P99 |
— Oxygen radicals |
L10, P108, P113, P117, P122 |
— Vasoactive peptides |
P188, P338, P99 |